Use of botulinum toxin in Parkinson's disease

Add time:08/12/2019    Source:sciencedirect.com

Botulinum toxin has emerged as an important therapeutic intervention within the realm of movement disorders, especially for focal and generalized dystonias. Botulinum toxin has additionally been used for a variety of symptoms associated with parkinsonism. In this review, we will specifically evaluate use of botulinum toxin in idiopathic Parkinson's disease. We will discuss symptoms including sialorrhea, limb, dystonia, tremor, dyskinesias, freezing of gait, camptocormia, pisa syndrome, urinary dysfunction, constipation, dysphagia, eyelid opening apraxia, and blepharospasm.

We also recommend Trading Suppliers and Manufacturers of Botulinum toxin G (cas 107231-16-3). Pls Click Website Link as below: cas 107231-16-3 suppliers

Prev:Original article2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: Structure activity relationships of the 2-oxy pyridine C-region
Next:Putrescine treatment reduces yellowing during senescence of broccoli (Brassica oleracea L. var. italica))